Pharma 4.0 – Digitalization and Transformation Conference 2024 | Conferenzia World | 5 June 2024 | TBA, Munich, Germany

In a world where every cell holds a secret and each pharmaceutical compound is a realm for discovery, the Summit returns as the catalyst for unraveling the complexities in pharmaceuticals and advanced therapeutic interventions. Join the convergence of leading professionals and seasoned experts as they share insights and deliberate on pertinent and trending topics in the industry such Smart Manufacturing in Bioprocessing and Pharma, Therapeutic Potentials of Extracellular Vesicles, AI and Machine Learning in Drug Discovery, Cybersecurity in Pharma 4.0 etc. While spreading enlightenment on these burning topics, there will be discussions on the application of environmentally conscious and socially responsible practices in the field of Bioprocessing and Pharma 4.0. By examining case studies and drawing insights from lessons learned, the summit aids in shaping the very future we have dared to imagine.

The Summit is an immersive two-day conference in the city of Munich, Germany that will explore the intersection of Bioprocessing and Pharma 4.0 as we bring together enlightened industry leaders to connect and exchange ideas. Gain invaluable insights that optimize continuous production, mitigate manufacturing risks, and discover the most advanced technologies in bioprocessing and pharma.

Welcome to the Global Bioprocessing & Pharma 4.0 Summit, the epicenter of Bioprocessing brilliance and Pharma 4.0 excellence, where each revelation propels us further into the realms of limitless potential.

Key Topics
• Nucleic Acid Therapeutics for Treating Central Nervous System Disorders
• Therapeutic Potentials of Extracellular Vesicles
• Breakthroughs in Cell Line Development for Superior Vaccines
• Intelligent Single-Use Technologies to Empower Autonomous Decision-Making
• Green Chemistry in Drug Development
• Advancements in Nanotechnology in Drug Delivery
• Cybersecurity in Pharma 4.0
• Smart Manufacturing in Bioprocessing and Pharma
• AI and Machine Learning in Drug Discovery
• Green Analytical Chemistry for Environmental Sustainability

2024 Speakers

Laurens Vergauwen
EMEA Senior Process, Development Scientist

Markus Karmasin
Vie Presidend and Global Franchise Head, Prostate Cancer, Novartis

Diego L. Sanmartin
Product Manager Oncology, Giledd

Steffen Achenback
Managing Director, dRx Capital, Novartis

Birte Scharf
Senior Scientist - GMP Compliance, Franz Ziel

Kamil Mroz
Program Management Lead, Early Drug Development, UCB